Zoticon BioVentures
Zoticon has invested over $100 million to date in promising phase III therapeutics including two oncology products and a cardiovascular
#FIRGUN
Remagine Ventures
Zoticon has invested over $100 million to date in promising phase III therapeutics including two oncology products and a cardiovascular
Stay close to Israeli venture
Short, useful notes on Israeli tech and venture. No clutter, just signal.